Tower Research Capital (TRC)
IBBQ icon

Tower Research Capital (TRC)’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Tower Research Capital (TRC)’s Portfolio IBBQ Stock Details IBBQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$496K Sell
15,194
-18,029
-54% -$535K 0.01% 1036
2026
Q1 		$963K Buy
+33,223
New +$967K 0.03% 553
2025
Q4 		– Sell
-3,861
Closed -$93.9K – 5344
2025
Q3 		$93.9K Buy
3,861
+3,485
+927% +$80.2K ﹤0.01% 2039
2025
Q2 		$7.94K Sell
376
-13,540
-97% -$278K ﹤0.01% 4031
2025
Q1 		$295K Sell
13,916
-14,145
-50% -$314K 0.01% 1153
2024
Q4 		$604K Buy
28,061
+16,768
+148% +$387K 0.01% 932
2024
Q3 		$269K Sell
11,293
-1,417
-11% -$33.8K 0.01% 1352
2024
Q2 		$289K Buy
12,710
+12,641
+18,320% +$276K ﹤0.01% 1797
2024
Q1 		$1.53K Sell
69
-9,276
-99% -$206K ﹤0.01% 5250
2023
Q4 		$205K Sell
9,345
-3,840
-29% -$75.6K ﹤0.01% 2085
2023
Q3 		$261K Sell
13,185
-14,761
-53% -$301K 0.01% 1270
2023
Q2 		$571K Buy
27,946
+11,122
+66% +$233K 0.02% 881
2023
Q1 		$348K Buy
16,824
+2,618
+18% +$54.9K 0.01% 1049
2022
Q4 		$299K Sell
14,206
-23,443
-62% -$485K 0.01% 1021
2022
Q3 		$712K Sell
37,649
-5,415
-13% -$107K 0.01% 880
2022
Q2 		$811K Sell
43,064
-3,289
-7% -$62.7K 0.02% 825
2022
Q1 		$970K Buy
46,353
+28,787
+164% +$597K 0.01% 799
2021
Q4 		$417K Buy
17,566
+8,182
+87% +$199K 0.01% 1234
2021
Q3 		$240K Sell
9,384
-316,245
-97% -$8.33M 0.01% 1641
2021
Q2 		$8.44M Buy
+325,629
New +$8.28M 0.22% 63

Other funds holding IBBQ

Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
WMS Group
WMS Group Folsom, Louisiana $77.5M AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Independent Advisor Alliance
Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return
Knightsbridge Asset Management
Knightsbridge Asset Management Newport Beach, California $762M AUM 59.13% 1-Year Est. Return
Advisory Services Network
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return
Churchill Financial Advisors
Churchill Financial Advisors Louisville, Kentucky $511M AUM 22.69% 1-Year Est. Return
Brinker Capital Investments
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
Clearstead Advisors
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Tower Research Capital (TRC)'s IBBQ Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Invesco NASDAQ Biotechnology ETF (IBBQ) stake by 54% in Q2 2026, selling an estimated $535K and leaving 15,194 shares worth $496K. The position accounts for 0.01% of the portfolio, ranked #1036.

Tower Research Capital (TRC) first reported a position in IBBQ in Q2 2021 and has held it in 20 quarters since. The position peaked at $8.44M in Q2 2021. 35 funds tracked by Wall St. Rank hold IBBQ as of Q2 2026.

  • Tower Research Capital (TRC) held 15,194 shares of Invesco NASDAQ Biotechnology ETF worth $496K as of Q2 2026.
  • Tower Research Capital (TRC) sold 18,029 Invesco NASDAQ Biotechnology ETF shares in Q2 2026, an estimated $535K.
  • Invesco NASDAQ Biotechnology ETF made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #1036 holding.
  • Tower Research Capital (TRC) first reported a position in Invesco NASDAQ Biotechnology ETF in Q2 2021 and has held it in 20 quarters since.
  • Tower Research Capital (TRC)'s Invesco NASDAQ Biotechnology ETF position peaked at $8.44M in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.